Q&A: In the Wake of Dobbs, Women’s Health is ‘Ripe for Investment’

The Supreme Court’s decision that overturned Roe v. Wade officially came down more than half a year ago, and abortion access has narrowed for a large portion of the country.

Elizabeth Bailey, managing director at RH Capital, said there are plenty of opportunities for digital health investors and startups to make waves in the women’s health space.

Though women’s health tech still makes up a relatively small portion of overall digital health funding, Bailey said the environment has changed since RH Capital, which focuses on reproductive and maternal health, raised its first fund in 2019. The topic isn’t niche anymore – and venture capital firms should be looking for those untapped opportunities.

Bailey sat down with MobiHealthNews to discuss the women’s health landscape, how the Dobbs decision has affected the market and how startups can effectively work in maternal health.

MobiHealthNews: What are the areas in women’s health that you think need more investment?

Elizabeth Bailey: Pretty much everywhere in women’s health. When you think about how little investment there’s been in the women’s health space, what it means is that innovations are needed across every area that you can think of, from endometriosis, to menopause, to STIs, to heart disease. I think if you’re talking about women’s health and medical conditions, I cannot think of one that is not ripe for investment and innovation. Read more.

Total
0
Shares
Related Posts